neuroATLANTIC aims to bring together the remarkable scientific and technological capacities found within the Atlantic Area in the field of the neurological diseases (e.g. Alzheimer’s Disease, stroke, etc.).
This project will act on the clinical, preclinical and capitalization aspects accelerating the uptake of new innovations that will revolutionize the way in which neurological diseases are handled within the area.
This project focuses on setting up a transnational platform to develop novel theragnostics agents for the treatment and early diagnosis of these devastating and prevalent diseases.
Company Details
- Founded
- 2019
- Address
- Fundación Instituto De Investigación Sanitaria De Santiago De Compostela, Hospital Clínico,edificio D,1º Andar Travesa Da Choupana S/n,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.neuroatlantic.eu
- Keywords
- Santiago de Compostela.
- HQ
- Santiago de Compostela, A Coruña
Neuroatlantic Questions
Neuroatlantic's website is http://www.neuroatlantic.eu
Neuroatlantic's LinkedIn profile is https://es.linkedin.com/company/neuroatlantic
Neuroatlantic's industry is
Research Services
Neuroatlantic's top competitors are
Centogene,
Bflow,
Genome4care,
Ego Pharmaceuticals,
Akoya Biosciences, Inc.,
Idt Australia Limited,
Denovo Biolabs,
Baxter Laboratories Pty Ltd,
Nanostring Genvip,
Nanostring Technologies, Inc..
Neuroatlantic's categories are Research Services
Neuroatlantic's founding year is 2019
